The latest trading day saw Medtronic (MDT) settling at $81.76, representing a +0.09% change from its previous close.
Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.

5 Expected Dividend Increases In May 2024

01:38am, Friday, 03'rd May 2024
5 Expected Dividend Increases In May 2024
Medtronic (MDT) closed at $80.86 in the latest trading session, marking a +1.4% move from the prior day.

My Best Dividend Aristocrats For May 2024

02:29pm, Monday, 29'th Apr 2024
My Best Dividend Aristocrats For May 2024
Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN , April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare
Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be
Medtronic (MDT) reachead $80.57 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.
Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.

Medtronic Stock: Buy, Sell, or Hold?

09:05am, Thursday, 18'th Apr 2024
The medical device maker's growth rate has averaged less than 2% in the past five years. However, it's still innovating and recently launched an AI-assisted endoscopy system.
Although dividend investing has plenty of research backing its efficacy, it's a slow burn. Further, it may incur high opportunity costs during broad-market rallies, such as what we saw during the bull
AI could solve one of the biggest problems in drug development: the lengthy time it takes to bring a product to market. The AI in healthcare market is set to expand at a compound annual growth rate of
Medtronic is a healthcare technology company that has seen encouraging growth in the current fiscal year. The company has maintained pricing power and has a strong balance sheet, with an A+ grade for
Medtronic is undervalued compared to its long-term P/E ratio and has potential for strong returns. The company's focus on innovation and product diversification positions it well for future growth.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE